BI
ProShares - UltraShort Nasdaq Biotechnology (BIS)
NASDAQ·Financial Services·Asset Management
$10.78
-1.60%
Mkt Cap $1.85M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$228.85
Range $155.22 – $268.65
Implied Upside
+2022.7%
Consensus $228.85 vs current $10.78